Research Expert: Sarah Overall
  • Published: Jun 2025
  • Pages: 150
  • SKU: IRTNTR76568

  • Latest News- Inhalation Anesthesia Market: Sevoflurane is expected to lead the Product segment during 2025-2029

    The Inhalation Anesthesia Market is being driven by Rising prevalence of cancer

    The Inhalation Anesthesia Market is expected to grow at a CAGR of 4.5% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 318.2 million. The global inhalation anesthesia market is witnessing robust expansion due to the escalating number of surgical procedures worldwide. Factors fueling this growth include an aging population, advancements in surgical techniques, and the rising prevalence of chronic diseases necessitating surgical intervention. Inhalation anesthesia, renowned for its precise anesthetic depth control and expedited recovery times, is gaining preference in numerous surgical procedures. Technological innovations in anesthesia delivery systems, which amplify precision and patient safety, further propel market growth. Moreover, the demand for shorter hospital stays and outpatient surgical procedures is surging, leading to heightened adoption of inhalation anesthesia for its expedited patient recovery and discharge. 

    Get more information on Inhalation Anesthesia Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on

    • Product
      • Sevoflurane
      • Desflurane
      • ISoflurane
      • Nitrous Oxide
      • Halothane
      • Others
    • Application
      • Maintenance
      • Induction
      • Sedation/Emergency Use
    • End-user
      • Hospitals
      • Ambulatory Surgical Centers
      • Specialty C
      • Academic and Research Institutionslinics
      • Veterinary Clinics
    • Route of Administration
      • Anesthesia Machines
      • Vaporizers
      • Portable Inhalers
    • Procedure Type
      • General Surgery
      • Orthopedic Surgery
      • Cardiac Surgery
      • Pediatric Surgery
      • Others
    • Distribution Channel
      • Direct Sales
      • Distributors
      • Online Channels
    • Geography
      • North America
        • Canada
        • US
      • Europe
        • Germany
        • UK
        • France
        • Italy
      • Asia
        • China
        • India
        • Japan
        • South Korea
      • Rest of World (ROW)

      According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

      • Rising prevalence of cancer
      • Rising elderly population
      • Adoption of unique marketing strategies by companies

      However, the market also witnesses some limitations, which are as follows:

      • Stringent regulations regarding usage of inhalation anesthesia
      • Adverse effects associated with inhalation anesthesia
      • General anesthetic risks in pediatric patients and pregnant women

      Benefits of Buying Global Inhalation Anesthesia Market Research Report by Technavio

      Rich Experience: 20+ years leading global market research, trusted insights across industries.

      Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

      Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

      Market Scope in Inhalation Anesthesia Market Research Report

      Market Scope

      Report Coverage

      Details

      Page number

      191

      Base year

      2024

      Historic period

      2019-2023

      Forecast period

      2025-2029

      Growth momentum & CAGR

      Accelerate at a CAGR of 4.5%

      Market growth 2025-2029

      USD 318.2 million

      Market structure

      concentration

      YoY growth 2024-2025(%)

      4.2

      Key countries

      US, Canada, China, UK, Germany, Japan, India, Italy, South Korea, and France

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Find out which segment is leading the market by accessing the free PDF report

      Research Analysis Overview

      The Inhalation Anesthesia Market has witnessed significant advancements in surgical history, addressing surgical disparities through improved surgical technology. Anesthesia risks, surgical site infections, and surgical workforce concerns are being addressed ethically with informed consent and recovery plans. Surgical safety is prioritized through simulation training, innovation, and perioperative care. Preoperative assessment, research, education, and postoperative pain management are essential components. Cardiovascular surgeries, planning, and drug development aim for surgical access and health equity. Sustainable healthcare, public health, patient safety, and healthcare costs are addressed through clinical trials, policy, and digital health solutions. The aging population requires innovative approaches to hospital management and pharmaceuticals, with a focus on telemedicine, disease prevention, and precision medicine.

      Market Research Overview

      The Inhalation Anesthesia Market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or production of anesthetic agents. This market's size is determined by Technavio, which calculates the combined revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Key growth drivers include the rising prevalence of anastomotic leaks, cardiovascular diseases, cancer, and elective surgeries, particularly in the aging population. By 2050, one-fourth of the US population and Europe's population ratio is predicted to be over 60 years old, increasing the demand for anesthesia during orthopedic and other surgical procedures. Despite these opportunities, challenges such as potential wound dehiscence and environmental degradation associated with anesthetic agents remain.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


      Contacts

      Technavio Research
      Jesse Maida
      Media & Marketing Executive
      US: +1 844 364 1100
      UK: +44 203 893 3200
      Email: media@technavio.com
      Website: www.technavio.com/

      Read News Read Less
      Interested in this report?
      Get your sample now!

    Safe and Secure SSL Encrypted

    Technavio

    • 2500 USD

    [5 reports/month/user]

    • 5000 USD

    close
    • Basic Plan [5000 USD/Year]:

      Single User
      Download 5 Reports/Month
      View 100 Reports/Month
      Add upto 3 Users at 625 USD/user

    • Teams Plan [7500 USD/Year]:

      5 User
      Download 5 Reports/Month/User
      View 100 Reports/Month/User
      Add upto 30 Users at 500 USD/user

    *You can upgrade to Teams plan at Subscription page

    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization).
      Complimentary Customization Included

    *For Enterprise license, go to checkout page

    Technavio Get the report (PDF) sent to your email within minutes.